Mark Purcell

Stock Analyst at Morgan Stanley

(1.04)
# 3,704
Out of 4,896 analysts
5
Total ratings
50%
Success rate
-9.99%
Average return
Main Sectors:

Stocks Rated by Mark Purcell

Novartis AG
Jan 23, 2024
Initiates: Equal-Weight
Price Target: $114
Current: $121.02
Upside: -5.80%
Sanofi
Jan 23, 2024
Initiates: Equal-Weight
Price Target: $55
Current: $48.61
Upside: +13.15%
GSK plc
Jan 23, 2024
Initiates: Equal-Weight
Price Target: $44
Current: $38.28
Upside: +14.94%
AstraZeneca
Jan 23, 2024
Initiates: Overweight
Price Target: $85
Current: $71.13
Upside: +19.50%
Novo Nordisk
Jan 23, 2024
Initiates: Overweight
Price Target: $120
Current: $68.93
Upside: +74.09%